← Back to directory

Stephanie Korn

Researcher Next ID · RN-025512

Researcher · Medicine

University of Applied Sciences Mainz

Mainz, Romania

Not currently recruitingFunding unknown
Works count
295
Citation count
11,703
H-index
44
i10-index
87

Research interests

Medicine
Asthma and respiratory diseases
Chronic Obstructive Pulmonary Disease (COPD) Research
Respiratory and Cough-Related Research
Allergic Rhinitis and Sensitization
Inhalation and Respiratory Drug Delivery

Publications

  • Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

    New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1708208

  • Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

    The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)31322-8

  • Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

    The Lancet Respiratory Medicine · 2015 · https://doi.org/10.1016/s2213-2600(15)00042-9

  • Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study

    BMC Pulmonary Medicine · 2014 · https://doi.org/10.1186/1471-2466-14-178

  • Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

    The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)60988-x

Current projects

    No projects listed.